Clinical Trials Logo

Clinical Trial Summary

Osteoarthritis is a disabling disease of the joint spaces and has a high impact on society due to the amount of people who are affected by the disease. Nonoperative management is a mainstay of therapy in most patients. Ketorolac tromethamine and triamcinolone acetonide intra-articular knee injections will be compared in a prospective, double-blinded, randomized trial in subjects with knee osteoarthritis. Subjects will be enrolled from the Orthopaedics Clinic based on inclusion and exclusion criteria. Intra-articular knee injection of ketorolac tromethamine or triamcinolone acetonide will be performed under ultrasound guidance. Multiple outcome measures will be performed throughout the six month period of follow-up. The investigators predict ketorolac tromethamine will have a longer duration of pain relief when compared to triamcinolone acetonide. The investigators predict there will be no differences between the two intra-articular knee injections in terms of function using validated scoring instruments.


Clinical Trial Description

Subject Population: Adult patients, age 18-90 years old who satisfy the inclusion criteria and do not meet the exclusion criteria will be enrolled from the Orthopaedics Clinic at San Antonio Military Medical Center (SAMMC). The enrollment period for this study is two years, patients will be recruited up to 44 enrollees to allow 36 completers. Patients will be stratified based on gender and age (< 65 or >= 65 years old). Demographics obtained will be age, gender, height, weight, laterality and body-mass index (BMI).

Randomization: This will be a predetermined computerized randomization schedule to identify treatment, ketorolac tromethamine versus triamcinolone acetonide. A patient key on paper listing the patient name, last four digits of sponsor's social security number, study number (randomly assigned), and treatment will be kept with the nurse/technician in the Orthopaedics Clinic, locked in a cabinet. Patients will be stratified by gender and age (< 65 or >= 65 years old). Subjects will continue to be enrolled until there are at least 10 of each gender in each group, treated with either ketorolac tromethamine or triamcinolone acetonide. In the event the subject has bilateral knee pain, both knees will be injected with the same treatment medication and the knee will be randomized as to which one will be included in the data analysis.

A pharmacist will prepare the treatment injection in the Orthopaedics Clinic. Injections will be done with a 2-inch, 21-gauge needle placed on a 10cc syringe with an opaque covering to conceal its contents to blind the patient and associate investigator to treatment. Injections will contain either 2cc of ketorolac tromethamine (Toradol, 15mg/cc) in 8cc of bupivacaine hydrochloride (0.5%) without epinephrine or 2cc of triamcinolone acetonide (Kenalog-40, 40mg/cc) in 8cc of bupivacaine hydrochloride (0.5%) without epinephrine. The subject and the treatment injection will be taken to the Interdisciplinary Pain Management Center, for injection under ultrasound guidance. The subject's selected knee, or bilateral knees, at the superolateral site, will be sterilely prepped in standard fashion with betadine and allowed to dry, prior to injection. The treatment will be injected by the associate investigator, in the Interdisciplinary Pain Management Center, who is trained in Physical Medicine and Rehabilitation and certified to perform ultrasound examinations. The associate investigator will be blinded to treatment and outcomes.

A patient key listing the patient name, last four digits of sponsor's social security number, age, gender, patient number (randomly assigned) and treatment received will be kept with the nurse/technician in the Orthopaedics Clinic in a research folder, locked in a cabinet.

Radiographs will be obtained at baseline and at 6 months follow-up. Osteoarthritis will be classified according to Kellgren-Lawrence (K-L) radiographic criteria by associate investigator who is fellowship trained in Total Joints. K-L grading will be entered on the Case Report Form (CRF) prior to outcome data entry. The associate investigator will be blinded to treatment. Outcome data collection will be performed by a study nurse/technician in the Orthopaedics Clinic, with the exception of part of the Knee Society Score (KSS), which will be performed by an associate investigator. The nurse/technician will record demographic data, including height, weight, BMI, gender, laterality and age, at the baseline clinic visit and at the 6 month follow-up. The use of nonsteroidal anti-inflammatory drug (NSAID) and analgesic drugs and adverse events during the study period will be recorded at each visit. Patients will keep a diary of NSAID and analgesic use during the study. Patients will follow-up at 2 weeks, 6 weeks, 3 months and 6 months. A visual analogue scale (VAS), KSS, Western Ontario and McMasters Universities (WOMAC) index, Short Form 36 (SF-36), University California Los Angeles (UCLA) Activity Score and Lysholm Knee Score (LKS) will be obtained at the baseline clinic visit and each follow-up. All data obtained from the study will be recorded on the CRF. All data collected will be kept with the nurse/technician in the Orthopaedics Clinic in a research folder, locked in a cabinet.

Data from the CRF will be entered into an electronic database on Excel by the principle investigator on a password protected computer. The database will be made available to the associate investigators electronically. Data analysis will be performed by the principle investigator which will also be performed on a password protected computer. All investigators will remain blinded to the treatment received, until all data analysis is performed. There will be no patient identifiers in the data provided to the investigators, only the patient number. The patient number is a number randomly assigned to the patient and is only identifiable in the patient key, which will be kept separate as above.

A sample size of 16 per group achieve 80% power to detect a difference of 1.6 (16mm) VAS comparing ketorolac tromethamine to triamcinolone acetonide intra-articular injections with estimated standard deviations of 1.56 and with a significance level (alpha) of 0.05. There is an expected drop-out rate of 20%, which implies a sample size of 20 subjects per group. Data analysis will be performed by the principle investigator and associate investigator who will be blinded to treatment until data analysis is complete. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02295189
Study type Interventional
Source San Antonio Military Medical Center
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date June 2014

See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A